New Double Mutant Coronavirus Discovered in San Francisco 1CARE Medical Diagnostics partners with specimen collection units and healthcare facilities to protect California
Suspected to be the cause of COVID-19 surge in India, a new double mutant coronavirus variant has been detected in San Francisco for the first time.
The San Francisco Chronicle reported that the mutation is defined as a “double mutant” because it comprises two mutations that make the virus attach to cells.
One case of the variant that was first identified in India has been confirmed by the Stanford Clinical Virology Lab. According to the Chronicle, the case is a Stanford Health Care clinic patient and probably took place in Santa Clara County. The Chronicle also mentioned that county health authorities are not looking into the new variant because the CDC has not tagged it yet as a case of concern.
Collecting specimen samples from trusted collection unit partners and healthcare facilities, 1CARE Medical Diagnostics facilities high-complexity testing such as COVID-19. It also offers a noninvasive testing option that is SalivaDirect™ as well as a complete vaccination program.
One of the mutations in the new strain is alike to the detected variants in Brazil and South Africa. The second mutation has been detected in a California variant. While the mutation is perceived to be more contagious than the original COVID-19 strain, it is not yet confirmed if it is more vaccine-resistant.
University of California San Francisco Infectious Disease Expert Peter Chin-Hong told the Chronicle that this is the first time that the same virus has been detected with two mutations.
Primary trial results conducted with vaccines presently approved for US use have shown that vaccines remain effective against variants. Chin-Hong also said that he was optimistic that they would also work on the “double mutant” strain.
Let 1CARE Medical Diagnostics help fight this pandemic with its comprehensive protection methods against COVID-19. Partner with us today.